Soricimed Biopharma Inc. Alternatives & Competitors

12 companies similar to Soricimed Biopharma Inc. — Dedicated to developing effective and novel targeted treatments for cancer.

Prescient Therapeutics

A clinical stage oncology company developing personalised medicine approaches to cancer; c...

14 Post-IPO Equity $3.00M

Australia

Biopharma Biotechnology +3

Anchiano Therapeutics

Dedicated to the discovery, development, and commercialization of novel targeted therapies...

1 Post-IPO Equity $42.00M

Cambridge, United States

Biotechnology Health Care +1

Genus Oncology LLC

Discovering New Frontiers in Anti-Cancer Therapeutics: Targeting MUC1 for a Healthier Tomo...

3 Series A

Biotechnology Health Care

Antikor Biopharma Ltd

Innovating in and developing the next generation of smaller-format ADCs for cancer therapy...

Stevenage, United Kingdom

Biotechnology Health Care

Track all Soricimed Biopharma Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Arno Therapeutics Inc (ARNI)

3 Post-IPO Equity $61.40M

Biopharma Biotechnology

Cavion

Empowering therapies for cancer and neurologic diseases through pioneering ion channel inh...

Series A $31.10M

Biotechnology Health Care +1

iOnctura

Developing precision small molecules to combat hard-to-treat tumors.

28 Series B $118.37M

Geneve, Switzerland

Biotechnology Health Care +2

AtG Therapeutics

Overcoming Tumor Adaptation - inhibiting escape mechanisms both in treatment naive and res...

7 Seed $556.00K

Spain

Biotechnology Health Care +1

BoomRay Pharmaceuticals

成为国际一流、品质卓越的放射性药物公司 Global pioneer in radiopharmaceuticals and commitme...

3 Series A $290.00M

Suzhou, China

Biopharma Biotechnology +1

Thelial Technologies

Discovering and developing targeted carcinoma therapies through innovative drug discovery...

Grant $410.00K

Biotechnology Health Care +1

SOLID Therapeutics

An early-stage oncology company aiming to treat solid tumors

Denmark

Arrogene, Inc.

Innovative cancer treatment technology delivering advanced nano agents to target tumors, e...

1 Venture round $7.90M

Biotechnology Health Care

About Soricimed Biopharma Inc.

Soricimed Biopharma Inc. is a privately-held, clinical stage company dedicated to developing effective and novel targeted treatments for cancer. Since the discovery of a unique protein found in the venomous saliva of the northern short-tailed shrew in 2005, the company is committed to developing effective, highly targe...

Taxonomy

Cancer Treatment, Targeted Therapy, Clinical Stage Company, Venomous Saliva Protein, Peptide Delivery, Therapeutics, Solid Tumor Cancers, Biomedical Innovation, Medical Discovery, Drug Development, Oncology, Precision Medicine, Biopharmaceuticals

Frequently Asked Questions

Companies similar to Soricimed Biopharma Inc. include Prescient Therapeutics, Anchiano Therapeutics, Genus Oncology LLC, Antikor Biopharma Ltd, Arno Therapeutics Inc (ARNI). They work in Biotechnology and Health Care and share Soricimed Biopharma Inc.'s focus on cancer treatment, precision medicine and oncology.

Bounce Watch lists 12 companies that share Soricimed Biopharma Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Soricimed Biopharma Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Soricimed Biopharma Inc. Profile Anchiano Therapeutics Alternatives Genus Oncology LLC Alternatives Antikor Biopharma Ltd Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Soricimed Biopharma Inc. on 11 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 8 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.